August 8, 2008

JOHNSON & JOHNSON: Unit to Appeal ‘221 Patent Invalidity Ruling

COMPANIES: Barr Laboratories Inc | Caraco Pharmaceutical Laboratories Ltd | Johnson & Johnson | Kali Laboratories Inc | Ortho-McNeil Pharmaceutical Inc | Par Pharmaceutical Inc | Teva Pharmaceuticals Industries Ltd
Subscribe

Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., intends to appeal the summary judgment decision invalidating the claims of U.S. Patent No. 39,221 (reissue patent).

The ‘221 patent claims combinations of acetaminophen…

TO CONTINUE READING,LOGIN or
TOPICS: Drugs/Pharmaceuticals | Health Care | Legal Issues, Litigation | Medical Supplies | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: New Jersey | North America | United States